AARON HAWKINS: Open Payments
NPI 1437415163 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,986 in 9 payments from 5 companies in 2025. Trend: 2023 $789 · 2024 $823 · 2025 $11,986
Debt forgiveness: $11,843Food & beverage: $143
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 1 | $11,843 |
| ABBVIE INC. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, REXULTI, CAPLYTA, INGREZZA.
Industry payments across AL — which companies pay providers there.
